BPC-157 30mg — Vial Spec, Reconstitution Math & COA

Overview and Mass Specification of the BPC-157 30mg Vial

The BPC-157 30mg vial is a large-format lyophilized presentation containing 30 milligrams of pure synthetic Body Protection Compound-157 (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). Designed for academic, industrial, and clinical-stage laboratory accounts requiring sustained dosing across extensive subject cohorts, this unit size minimizes batch variability by allowing investigators to draw from a single validated lot over an entire study duration.

While standard 5mg or 10mg vials are typical for pilot investigations, the 30mg vial serves high-volume screening operations. PX1 Research supplies high-purity research compounds across various scales; researchers seeking standard single-subject or low-volume options can explore our core BPC-157 product page or view our complete inventory via all peptides. Every 30mg vial is sealed under an inert nitrogen atmosphere in a clear USP Type I borosilicate glass vial to prevent moisture ingress and oxidative degradation.

Preclinical Research Focus and Biological Mechanism

In preclinical literature, BPC-157 is recognized as a tissue repair peptide evaluated primarily for its role in structural tissue organization and cell survival dynamics. In vitro assays and rodent models demonstrate that BPC-157 modulates focal adhesion kinase (FAK) and paxillin signaling pathways, which are critical for fibroblast migration and cellular attachment during extracellular matrix formation.

Furthermore, animal studies suggest that BPC-157 promotes localized angiogenesis through the upregulation of vascular endothelial growth factor (VEGF) expression and activation of the VEGFR2 pathway. This mechanism has made the peptide a primary subject of study in model systems evaluating accelerated repair of tendon, ligament, skeletal muscle, and gastrointestinal gut lining lesions. Investigators exploring these pathways often combine cellular migration assays with structural histological staining to evaluate microvascular capillary outgrowth.

Reconstitution Mathematics: Diluent Volume Calculations for 30mg

Reconstituting a 30mg lyophilized cake requires precise concentration mapping to ensure volumetric accuracy during micro-pipetting or automated fluid handling. Due to the higher mass of active peptide, larger diluent volumes or concentrated stock preparations are commonly utilized depending on the sensitivity of the experimental assay.

When using Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride solution as the diluent, the resulting working concentrations for a 30mg vial are defined as follows:

1. Reconstitution with 1.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30,000 µg/mL). At this concentration, a 0.01 mL (10 µL) aliquot delivers 300 µg of BPC-157. This dense concentration is suitable for small-volume micro-injection models or stock solution preparation. 2. Reconstitution with 2.0 mL Diluent: Yields a final concentration of 15.0 mg/mL (15,000 µg/mL). Here, a 0.01 mL (10 µL) aliquot delivers 150 µg of peptide. This dilution offers a balance between fluid volume and measurement precision. 3. Reconstitution with 3.0 mL Diluent: Yields a final concentration of 10.0 mg/mL (10,000 µg/mL). At this level, a 0.01 mL (10 µL) aliquot delivers 100 µg of active compound, allowing precise linear scaling for rodent bioassays. To model alternate volume-to-concentration ratios or calculate custom aliquoting protocols, researchers should utilize our interactive reconstitution calculator.

Aliquot Planning and Laboratory Assay Stability

Reconstituting 30mg of peptide in a single vial creates a substantial volume of liquid stock. Repeated freeze-thaw cycles or prolonged storage at room temperature significantly accelerate hydrolytic cleavage of the peptide backbone. To preserve structural stability across multi-week assays, research teams must establish a rigorous aliquoting protocol immediately following initial dissolution.

Once fully dissolved by gentle swirl technique—never aggressive vortexing—the stock solution should be divided into single-use or single-day volumetric aliquots using sterile, polypropylene microcentrifuge tubes. Aliquots designated for immediate use within 48 to 72 hours should be stored at 2°C to 8°C. Sub-aliquots planned for future study phases must be flash-frozen and maintained at -20°C or -80°C to prevent degradation over extended periods.

Quality Control Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

Large-format lyophilized peptides require stringent analytical controls to verify total mass, molecular identity, and overall purity. PX1 Research subjects every synthesis batch to rigorous third-party analytical testing within ISO 17025 accredited testing facilities.

High-Performance Liquid Chromatography (HPLC) is conducted to determine chemical purity, ensuring every lot meets or exceeds a minimum threshold of 99.0% purity. Mass Spectrometry (MS) confirms the precise molecular weight of 1419.53 Da, ruling out truncated sequences or synthesis side products. Additionally, because high-concentration preparations are frequently used in cell culture and sensitive in vivo models, every batch undergoes chromogenic LAL testing to verify endotoxin levels remain below standard laboratory thresholds. Every shipment includes a direct, lot-matched analytical report accessible via our dedicated COA repository.

Format Selection: 30mg Bulk Vials vs. Standard 5mg and 10mg Formats

Selecting between a 30mg mass vial and standard 5mg or 10mg options depends on study design, handling capabilities, and consumption timelines. While a 30mg vial offers significant efficiency for continuous, high-volume research protocols, smaller vial sizes may be preferable for low-throughput screening to minimize the duration a reconstituted solution remains in liquid storage.

For small pilot studies or intermittent assays, utilizing individual 5mg vials limits the operational impact of potential contamination or temperature excursion. Conversely, high-throughput laboratories operating automated liquid handlers benefit from the continuous batch uniformity provided by the 30mg presentation. Laboratory procurement departments can review bulk pricing and account options via our wholesale portal.

Comparative Analysis: Synthetics in Preclinical Regenerative Protocols

In preclinical investigations focused on tissue repair and cell survival mechanisms, BPC-157 is frequently evaluated alongside or in comparison with other synthetic signaling peptides. Understanding the distinct structural properties and receptor targets of these related compounds is essential for robust experimental design.

While BPC-157 primarily acts via FAK-paxillin pathway modulation and localized VEGF expression, researchers studying cell migration often examine TB-500 (Thymosin Beta-4 fragment) for its actin-sequestering capabilities and influence on cell motility. In studies focused on systemic growth factor dynamics and metabolic modulation, peptides such as CJC-1295 and Ipamorelin are frequently employed to evaluate growth hormone secretagogue receptor activation. Comparing these distinct classes allows investigators to isolate direct extracellular matrix remodeling from systemic endocrine signaling.

Storage, Degradation Pathways, and Handling Guidelines

Lyophilized BPC-157 is stable at controlled room temperature for short transport periods, but long-term preservation requires controlled environmental conditions. Lyophilized vials should be stored upon arrival at -20°C in a dry, dark environment to prevent moisture absorption and light-induced cleavage.

Upon reconstitution, the peptide becomes sensitive to thermal variation and mechanical agitation. Avoid vigorous shaking during dissolution, as shear stress can induce peptide aggregation or structural altercations. Reconstituted liquids must remain refrigerated at 2°C to 8°C and should be utilized within 14 to 21 days when stored with bacteriostatic preservatives. For comprehensive handling protocols and study literature, visit our central research hub.